0
Articles   |    
Effect of Cultured Autologous Chondrocytes on Repair of Chondral Defects in a Canine Model*
HOWARD A. BREINAN, M.S.†; TOM MINAS, M.D.†; HU-PING HSU, M.D.†; STEFAN NEHRER, M.D.‡; CLEMENT B. SLEDGE, M.D.†; MYRON SPECTOR, PH.D.†, BOSTON, MASSACHUSETTS
View Disclosures and Other Information
Investigation performed at the Department of Orthopedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston
The Journal of Bone & Joint Surgery.  1997; 79:1439-51 
5 Recommendations (Recommend) | 3 Comments | Saved by 3 Users Save Case

Abstract

Articular cartilage has a limited capacity for repair. In recent clinical and animal experiments, investigators have attempted to elicit the repair of defects of articular cartilage by injecting cultured autologous chondrocytes under a periosteal flap (a layer of periosteum). The objective of the present study was to determine the effect of cultured autologous chondrocytes on healing in an adult canine model with use of histomorphometric methods to assess the degree of repair.A total of forty-four four-millimeter-diameter circular defects were created down to the zone of calcified cartilage in the articular cartilage of the trochlear groove of the distal part of the femur in fourteen dogs. The morphology and characteristics of the original defects were defined in an additional six freshly created defects in three other dogs. Some residual non-calcified articular cartilage, occupying approximately 2 per cent of the total cross-sectional area of the defect, was sometimes left in the defect. The procedure sometimes damaged the calcified cartilage, resulting in occasional microfractures or larger fractures, thinning of the zone of calcified cartilage, or, rarely, small localized penetrations into subchondral bone.The forty-four defects were divided into three treatment groups. In one group, cultured autologous chondrocytes were implanted under a periosteal flap. In the second group, the defect was covered with a periosteal flap but no autologous chondrocytes were implanted. In the third group (the control group), the defects were left empty.The defects were analyzed after twelve or eighteen months of healing. Histomorphometric measurements were made of the percentage of the total area of the defect that became filled with repair tissue, the types of tissue that filled the defect, and the integration of the repair tissue with the adjacent cartilage at the sides of the defects and with the calcified cartilage at the base of the defect. In histological sections made through the center of the defects in the three groups, the area of the defect that filled with new repair tissue ranged from a mean total value of 36 to 76 per cent, with 10 to 23 per cent of the total area consisting of hyaline cartilage. Integration of the repair tissue with the adjacent cartilage at the edges of the defect ranged from 16 to 32 per cent in the three groups. Bonding between the repair tissue and the calcified cartilage at the base of the defect ranged from 41 to 89 per cent.With the numbers available, we could detect no significant difference among the three groups with regard to any of the parameters used to assess the quality of the repair. In the two groups in which a periosteal flap was sutured to the articular cartilage surrounding the defect, the articular cartilage showed degenerative changes that appeared to be related to that suturing.CLINICAL RELEVANCE: The technique of injecting cultured autologous chondrocytes under a periosteal flap recently was introduced to treat defects in the articular cartilage of humans. The long-term efficacy of this treatment is unknown. An animal model was developed to evaluate the procedure and its effectiveness.

Figures in this Article
    The treatment of defects of articular cartilage with an injection of cultured autologous chondrocytes under a periosteal flap has been described in recent clinical and experimental studies1,2,4. In each of those studies, defects were produced by scraping away articular cartilage to the zone of calcified cartilage. In the procedures, an attempt was made to maintain an intact subchondral bone plate. The clinical study2, which included follow-up for sixty-six months, demonstrated a general decrease in symptoms, with better results for the defects in the femoral condyle than for those in the patella. Examination of biopsy specimens obtained at twelve to forty-six months revealed reparative tissue similar to hyaline cartilage in the femoral defects, whereas the patellar defects contained fibrous-hyaline cartilage. Studies of this procedure in a rabbit model indicated that the use of cultured autologous chondrocytes could increase the amount and quality of repair tissue compared with that in control groups in which defects were covered with periosteum only or were not treated1. The reparative tissue was found to mature gradually over a period of as long as one year, with formation of tissue similar to hyaline cartilage but with incomplete bonding of the repair tissue to the adjacent cartilage.
    Because of the potential value of this procedure, an additional and more detailed study in an animal model was deemed important. The objective of the present study was to determine the effect of cultured autologous chondrocytes on healing in an adult canine model. Defects were created down to the zone of calcified cartilage in the trochlear groove of the distal part of the femur, just as was done in the clinical procedure, and cultured autologous chondrocytes were injected under a periosteal flap. The method of treatment was similar to that used in humans and in the rabbit model1-3. The treated defects were compared with the untreated defects and with those treated with only a periosteal flap. Quantitative histomorphometry was used to evaluate the types of tissue within the lesions.

    *One or more of the authors has received or will receive benefits for personal or professional use from a commercial party related directly or indirectly to the subject of this article. In addition, benefits have been or will be directed to a research fund, foundation, educational institution, or other non-profit organization with which one or more of the authors is associated. Funds were received in total or partial support of the research or clinical study presented in this article. The funding sources were Genzyme Tissue Repair, Cambridge, Massachusetts, and the Veterans Administration Rehabilitation Research and Development Service.

    †Orthopedic Research Laboratory, Department of Orthopedic Surgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, Massachusetts 02115. E-mail address for Dr. Spector: spector@ortho.bwh.harvard.edu.

    ‡Department of Orthopedic Surgery, University of Vienna, Wahringer Guertel 18-20, A-1090, Wien, Austria.

    *One or more of the authors has received or will receive benefits for personal or professional use from a commercial party related directly or indirectly to the subject of this article. In addition, benefits have been or will be directed to a research fund, foundation, educational institution, or other non-profit organization with which one or more of the authors is associated. Funds were received in total or partial support of the research or clinical study presented in this article. The funding sources were Genzyme Tissue Repair, Cambridge, Massachusetts, and the Veterans Administration Rehabilitation Research and Development Service.
    †Orthopedic Research Laboratory, Department of Orthopedic Surgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, Massachusetts 02115. E-mail address for Dr. Spector: spector@ortho.bwh.harvard.edu.
    ‡Department of Orthopedic Surgery, University of Vienna, Wahringer Guertel 18-20, A-1090, Wien, Austria.
     
    Anchor for JumpAnchor for Jump
    +Figs. 1-A through 1-D: Light micrographs of specimens from the fresh, untreated defects. The adjacent cartilage, stained red with safranin O, is visible to one side of each defect (solid arrow). The subchondral bone (SCB) is stained blue with fast green. Fig. 1-A: Specimen from the outlier defect, which had the most residual cartilage (RC) at the base.
     
    Anchor for JumpAnchor for Jump
    +Fig 1-B Specimen from one of two defects that had injury through the calcified cartilage caused by the curet. The marrow space was violated near the edge of the defect (open arrow).
     
    Anchor for JumpAnchor for Jump
    +Fig. 1-C Specimen from a defect in which the most residual cartilage is in a corner and there is a corner fracture (open arrow) through the calcified cartilage. The calcified layer to the right of the residual cartilage is thinned and has several microfractures (small arrows).
     
    Anchor for JumpAnchor for Jump
    +Fig. 1-D Specimen from a defect from which virtually all articular cartilage had been removed to the level of the tidemark.
     
    Anchor for JumpAnchor for Jump
    +Fig. 2 Light micrograph of reparative tissue from three specimens that had safranin-O and fast-green staining after eighteen months of healing. Each defect has a fully intact plate of subchondral bone and more-than-average filling. The arrowheads indicate the approximate borders of the defects at the surface. Variable loss of safranin-O staining in adjacent cartilage is visible in all three specimens. A: Specimen from a defect in which cultured autologous chondrocytes were implanted. There is bone formation in the deep layers of the center of the defect with good integration with adjacent cartilage. B: Specimen from a defect that was covered with periosteum alone. C: Specimen from an empty defect.
     
    Anchor for JumpAnchor for Jump
    +Fig. 3 Light micrograph showing reparative tissue in the center eighteen months after implantation of cultured autologous chondrocytes (trichrome). Hyaline cartilage (HC) formed at the base of the defect. Transitional tissue (TT) overlays the hyaline cartilage and is smoothly integrated in places. Hyaline cartilage bonded to calcified cartilage (CC). SCB = subchondral bone.
     
    Anchor for JumpAnchor for Jump
    +Fig. 4 Light micrograph (the same specimen as in Fig. 2, B) showing reparative tissue at the edge of a defect eighteen months after coverage with periosteum alone (trichrome). Newly formed tissue consists of transitional tissue (TT) and hyaline cartilage (HC), including a portion similar to articular cartilage (AC). The hyaline cartilage bonded to the calcified cartilage (CC). Evidence of poor bonding of reparative tissue to the adjacent cartilage is visible at the edge of the defect (arrowhead).
     
    Anchor for JumpAnchor for Jump
    +Fig. 5 Light micrograph showing reparative tissue at the edge of the specimen eighteen months after creation of a defect that was left untreated. Hyaline cartilage (HC) formed only in the corner of the defect while most of the defect was filled with transitional tissue (TT). Substantial cloning of chondrocytes is seen in the hyaline cartilage. The collagen fibers of the transitional tissue are not continuous with the calcified cartilage (CC), indicating apposition instead of bonding as seen with hyaline cartilage. Poor bonding of reparative tissue to the adjacent cartilage is seen at the edge of the defect (arrowhead). SCB = subchondral bone.
     
    Anchor for JumpAnchor for Jump
    +Figs. 6-A, 6-B, and 6-C: Light micrographs showing relatively poor repair (safranin O-fast green) after eighteen months of healing. The arrowheads indicate the approximate borders of the defects at the surface. Fig. 6-A: Specimen from a defect in which cultured autologous chondrocytes had been implanted. The defect is predominantly empty, and there is evidence of remodeling in the subchondral bone (open arrow).
     
    Anchor for JumpAnchor for Jump
    +Fig. 6-B Specimen from a defect that was covered with periosteum alone. The defect is empty except in the corner, where there is a small amount of hyaline cartilage (open arrow). The adjacent cartilage still shows the path of a suture (solid arrow), with obvious mechanical disruption and loss of some safranin-O staining. The damage of subchondral bone is an artefact of processing.
     
    Anchor for JumpAnchor for Jump
    +Fig. 6-C Specimen from an empty defect. There is substantial erosion of the calcified cartilage to the left of the open arrow, with accompanying resorption of the underlying bone. Fibrocartilaginous transitional tissue (TT) fills portions of the defect and the bone.
     
    Anchor for JumpAnchor for Jump
    +Fig. 7 Bar graph showing the composition of the tissue found in the full-thickness defects as a function of time and treatment. The percentages are mean values. The group of fresh, untreated defects also is shown in order to depict the level of residual cartilage left in the lesions. The total height of the column represents the total filling of the defect. With analysis of variance, we could detect no differences among the treatment groups with regard to any type of tissue (p > 0.05). CAC = implantation of cultured autologous chondrocytes, P = coverage with a periosteal flap only, and EC = no treatment.
     
    Anchor for JumpAnchor for Jump  TABLE I FILLING OF DEFECTS BY DIFFERENT TYPES OF TISSUE*
    *The values are given as the mean and the standard error of the mean for the percentage of the total area of the defect filled with a particular type of tissue. N = number of defects.†Subset of hyaline cartilage that has characteristics of articular cartilage, including columnar arrangement of cells and strong safranin-O staining of matrix for proteoglyans.‡The total value does not include the values for matrix flow or the subset of hyaline cartilage.§Given for the individual defects.
    At Twelve MonthsAt Eighteen Months
    Type of tissueDefects Treated with Cult. Autol. Chondrocytes (N = 8)Defects Treated with Periosteum Only (N = 6)Empty Defects (N = 8)Defects Treated with Cult. Autol. Chondrocytes (N = 8)Defects Treated with Periosteum Only (N = 6)Empty Defects (N = 6)
    Matrix flow3 ± 13 ± 22 ± 12 ± 12 ± 12 ± 1
    Fibrous tissue2 ± 12 ± 11 ± 12 ± 12 ± 18 ± 3
    Transition tissue19 ± 828 ± 1417 ± 828 ± 841 ± 852 ± 8
    Hyaline cartilage15 ± 316 ± 1323 ± 513 ± 410 ± 310 ± 2
    Articular cartilage†0.5 ± 0.32 ± 24 ± 20.3 ± 0.30.4 ± 0.40 ± 0
    Bone0 ± 02 ± 10.2 ± 0.23 ± 30 ± 06 ± 6
    Total36 ± 1048 ± 1041 ± 446 ± 853 ± 676 ± 18
    Range§13—7117—7328—7216—7614—7942—36
     
    Anchor for JumpAnchor for Jump  TABLE II BONDING OF REPARATIVE TISSUE TO CALCIFIED CARTILAGE AND TO ADJACENT CARTILAGE*
    *The values are given as the mean and the standard error of the mean for the percentage of the total length of the calcified cartilage or the articular cartilage that was bonded to the reparative tissue.
    At Twelve MonthsAt Eighteen Months
    Defects Treated with Cult. Autol. Chrondrocytes (N = 8)Defects Treated with Peristeum Only (N = 6)Empty Defects (N = 8)Defects Treated with Cult. Autol. Chrondrocytes (N = 8)Defects Treated with Periosteum Only (N = 6)Empty Defects (N = 6)
    Calcified cartilage60 ± 1244 ± 2989 ± 1059 ± 2047 ± 1441 ± 16
    Adjacent cartilage21 ± 432 ± 416 ± 822 ± 516 ± 725 ± 9
     
    Anchor for JumpAnchor for Jump  TABLE III GRADING OF ABNORMAL CHANGES IN ARTICULAR CARTILAGE AND BONE IN THE DEFECTS*
    *The data combines the results at the twelve and eighteen-month examinations, and the values are given as the number of defects. N = number of defects.†0 points = severe change, 1 point = moderate change, 2 points = slight change, and 3 points = normal findings or no change.
    Changes in Adjacent Articular Cartilage†
    Changes in Bone†Loss of Safranin-O StainingCloningSurface IntegrityDeep-Tissue Integrity
    0 Points1 Point2 Points3 Points0 Points1 Point2 Points3 Points0 Points1 Point2 Points3 Points0 Points1 Point2 Points3 Points0 Points1 Point2 Points3 Points
    Defects treated with cultured autologous chondrocytes (n=16)4174922326620210402311
    Defects treated with periosteum only (n=12)11466132245101650138
    Empty defects (n=14)1211002931571128310112

    Experimental Procedure

    Fourteen adult mongrel dogs that each weighed approximately thirty kilograms were used in the study. Before inclusion in the study, the animals were examined roentgenographically to exclude those that had degenerative joint disease of the knee. Two four-millimeter-diameter defects were created in the trochlear groove of both femora of eight dogs and in the right femur of six dogs, for a total of forty-four defects. All operations were performed with the dogs under general anesthesia and with use of a sterile technique. A four-millimeter-diameter dermal punch was used to outline the defect. With use of loupe visualization, an attempt was made to remove all non-calcified cartilage from the defect by scraping with a customized curet, without damaging the calcified cartilage. The objective was to remove as much articular cartilage as possible without leaving residual articular cartilage that might interfere with healing or affect the validity of the histomorphometric measurements. Although no bleeding from the subchondral bone was noted during the operation, an evaluation that was performed immediately after the creation of six additional defects showed that the operative procedure did, in fact, sometimes penetrate the calcified cartilage. The two defects in each knee were placed approximately 1.25 and 2.25 centimeters proximal to the intercondylar notch, slightly lateral or medial to the midline. Before the capsule was closed, bleeding vessels were clamped and cauterized. The knee joint was closed by zero-point suturing.
    In one treatment group, cultured autologous chondrocytes were implanted under a periosteal flap (sixteen defects in eight animals). In the second group, the defect was covered with a periosteal flap without implantation of autologous chondrocytes (twelve defects in six animals). In the third group (the control group), the defects were left empty (sixteen defects in eight animals). In eight dogs, the two defects in one knee were treated with cultured autologous chondrocytes and the two defects in the other knee were left untreated. The remaining six dogs had all twelve defects treated with periosteum only. The defects were evaluated after twelve or eighteen months of healing.
    As mentioned, an additional six fresh defects were examined immediately after they had been created. These defects, which were identical to those used for the treatment groups, were created in three dogs from a related study immediately after the animals had been killed. The defects were evaluated in order to demonstrate the extent of the original lesion.

    Treatment Protocol

    In the group that was to receive cultured autologous chondrocytes, tissue was removed from the lateral and medial margins of the articular cartilage of the distal part of the left femur for use in the culture of the chondrocytes. At that time, two defects also were created in the trochlear groove of the left femur and were not treated; these were the control (empty) defects. After the procedure, the dogs were allowed free activity in the cages. The cartilage from the defects and the margins was sent to Genzyme Tissue Repair (Cambridge, Massachusetts), where the cells were isolated and expanded in culture. Three weeks later, the cultured autologous chondrocytes were provided for injection in a tuberculin syringe with a 22-gauge blunt-end needle. Defects for treatment were prepared in the contralateral femur as already described. Periosteum was obtained from the proximal part of the tibia, and a four-millimeter-diameter circular periosteal flap, with the cambium layer facing the base of the defect, was placed over the defect and sutured with use of 8-0 sutures to the articular cartilage surrounding the defect. Cultured autologous chondrocytes in culture medium were injected under the periosteum (2 x 106 cells per defect). The defect was sealed with autologous fibrin, as has been reported previously4. In brief, autologous fibrinogen was isolated by cryoprecipitation from the blood of the animal several weeks before the operation. At the operation, the frozen cryoprecipitate was thawed and one milliliter of the substance was drawn into a syringe. One milliliter of a solution of bovine thrombin (Parke-Davis, Morris Plains, New Jersey), at a concentration of five units per milliliter with 0.5 per cent calcium chloride and ten milligrams of aminocaproic acid per milliliter, was provided in a separate syringe. After the area of the defect was dried, the contents of both syringes were simultaneously injected into a sterile container, mixed, and spread to cover the entire surface of the periosteal flap and the immediately adjacent cartilage. The incision was closed, and the knee was immobilized with use of external fixation (IMEX Veterinary, Longview, Texas) for ten days to prevent dislodging of the graft or the reparative tissue.
    In the group in which the defect was treated with periosteum alone, only the right knee was operated on and the procedure was the same as that for the group in which cultured autologous chondrocytes were implanted under a periosteal flap except that the cells were not used.

    Processing of Tissues

    The animals were killed with an injection of ten milliliters of pentobarbital sodium CII solution (0.6 milligram per milliliter). At that time, the defects were examined grossly and photographed. The distal part of each femur was excised and placed in 10 per cent neutral buffered formalin. Several hours later, each trochlea was carefully dissected with a fine-tooth coping saw and placed in formalin for four days. The trochlea was rinsed of formalin, dissected further into individual specimens approximately five millimeters thick, and placed into 15 per cent disodium EDTA decalcifying solution (pH 7.4). The sample was placed on a shaker at 4 degrees Celsius, and the decalcifying solution was changed three times each week for four weeks. The specimens were rinsed thoroughly, dehydrated, and embedded in paraffin at 60 degrees Celsius. Seven-micrometer-thick sections were prepared and were stored at 4 degrees Celsius.

    Light Microscopy

    Sections were stained with trichrome or safranin O-fast green. One section from the middle portion of each defect was analyzed. Light microscopy was performed with a Vanox AHBT research microscope (Olympus America, Melville, New York). Polarized light microscopy also was used to reveal the orientation of the collagen.
    The quantified features included the specific types of tissue filling the defect, the integration of reparative tissue with the calcified cartilage and with the adjacent articular cartilage surrounding the defect, and the integrity of the calcified cartilage layer. The histological characteristics of the surrounding cartilage and bone also were described.

    Quantitative Analysis

    Quantitative analysis of the entire defect area of the selected sections was performed with the aid of an eyepiece reticle inscribed with a square grid of ten lines by ten lines. The geometry of the defect first was defined and then certain healing characteristics were determined as an areal or a linear percentage of the appropriate parameters. These percentages refer only to the representative histological cross section through the middle portion of the defect.
    Grading was performed at a magnification of 100 times, with each grid-opening measuring sixty micrometers on each edge. The area of the defect was calculated as a rectangle of the base (b), which was equal to the distance along the base of the defect at the tidemark, and the height (h), which was equal to the mean height of the articular cartilage 600 micrometers lateral to each of the two edges of the defect. The height was recorded at a distance from the margins in this standard manner to reflect the original height of the defect; the height of the cartilage at the edge of the healing defect normally was slightly depressed relative to the original height of the cartilage, a finding associated with rounding of the surface at the edge of the defect. The mean dimensions of a defect in histological cross section were approximately 0.64 by 3.4 millimeters. The area of each specific type of tissue within the defect was measured by counting the number of grid-openings containing that specific type of tissue. The actual shape of the defect was a trapezoid, as the heights of the cartilage on either side were not necessarily identical. Dividing the area of the specific type of tissue by the total area of the defect yielded an areal percentage.
    Additional quantitative measurements included the percentage of the total length of the base of the defect (0 to 100 per cent) that was bonded to the repair tissue and the percentage of the total length of the edges of the defect (0 to 100 per cent) over which repair tissue was integrated with the adjacent cartilage. Bonding to the calcified cartilage was demonstrated by polarized light. Perpendicular orientation of collagen fibers to the tidemark and apparent continuity of the fibers from calcified to non-calcified layers were used as criteria to assess the bonding of the reparative tissue to the calcified cartilage. However, the determination of bonding to the adjacent cartilage was more difficult. The final parameter recorded was the percentage of the length of the calcified cartilage that had a normal appearance (0 to 100 per cent).

    Analysis of the Fresh Defects

    Each of the six fresh untreated defects in the dogs from the related study was serially sectioned through approximately 60 per cent of its width. At least eight sections, spaced approximately 250 micrometers apart, were examined.
    The amount of articular cartilage remaining in the defect was determined in three transverse sections made through the middle of the lesion. The parameters, related to the inability to remove all cartilage to the tidemark, were expressed as the percentage of the total area of the defect consisting of cartilage remaining in the corners of the defect, the percentage of the total area of the defect consisting of cartilage remaining elsewhere on the base of the defect, the percentage of the length of the base of the defect covered by residual articular cartilage, and the percentage of the base with damaged calcified cartilage. Calcified cartilage was described as damaged if there was evidence of thinning or there were fractures more than twenty micrometers wide or thirty micrometers deep from the tidemark. Smaller fractures, termed microfractures, were not considered damage.

    Criteria for the Identification of Specific Types of Tissue

    Four types of tissue (fibrous tissue, transitional tissue, hyaline cartilage, and bone) were distinguished on the basis of the appearance of their cells and matrix when examined by regular and polarized light microscopy. Safranin-O staining was used to identify the presence of sulfated glycosaminoglycans.
    Fibrous tissue consisted of spindle-shaped cells with bipolar tapered ends and elongated nuclei. The cells were intimately associated with surrounding collagenous matrix and did not reside in lacunae. The matrix contained collagen fibers oriented parallel to each other, which formed bundles roughly parallel to the surface. The collagen fibers were clearly visible at low power under polarized light, and the matrix did not stain positively for glycosaminoglycans.
    Transitional tissue had characteristics intermediate between fibrous tissue and hyaline cartilage. Some areas of matrix stained for glycosaminoglycans. The visibility of fibers in the matrix distinguished this tissue from hyaline cartilage. Cells were rounded and often resided in lacunae, thus distinguishing transitional tissue from fibrous tissue.
    Hyaline cartilage was identified primarily by the appearance of its cells and matrix. No individual collagen fibers or bundles were visible in the matrix. The hyaline matrix also had a distinctive appearance under polarized light, with diffuse transmission through the matrix except where the large collagen bundles were seen inserting into the calcified cartilage at the tidemark. Cells displayed a spherical morphology (except those near the surface, which usually were elongated as in normal articular cartilage). Normally, the cells in hyaline cartilage have well developed lacunae, and pericellular staining by safranin O is more intense than interterritorial matrix staining. However, tissue lacking normal safranin-O staining or a cellular appearance was seen and graded as hyaline cartilage. Portions of hyaline cartilage that met the histological criteria of articular cartilage, including complete matrix staining and a columnar arrangement of cells, were recorded as a subset of hyaline cartilage.
    In many specimens, the adjacent cartilage flowed into the peripheral regions of the defect, crossing an imaginary line rising normal to the base of the defect at the edge. This material was recorded separately as matrix flow and not as one of the four types of tissue.

    Semiquantitative Grading

    Semiquantitative grading of damage or degenerative changes in the articular cartilage and bone in the defects was performed, with scores ranging from 0 to 3 points. A score of 0 points indicated severe damage or degenerative change; 1 point, moderate degenerative change; 2 points, slight degenerative change; and 3 points, tissue similar to normal cartilage. The categories that were examined included the state of the subchondral bone and the effects on the adjacent cartilage, specifically staining for glycosaminoglycans, cloning, and the integrity of the surface and deeper tissues.

    Statistical Methods

    Comparisons were made on the basis of the averaged data from the two defects in each knee of all the animals in the treatment group. Two-way analysis of variance was performed to determine the effects of treatment and time on the types of tissue appearing in the defects. Student t tests were used to determine the significance of differences in results between selected groups. The level of significance was p < 0.05 for all tests.

    Morphology and Characteristics of the Fresh Defects

    In the six fresh defects that were examined immediately after they had been created in order to demonstrate the extent and characteristics of the original defects, the residual cartilage occupied a mean (and standard deviation) of 1.7 ± 2.1 per cent (range, 0.2 to 6.0 per cent) of the total area of the defect. Residual cartilage in the corners occupied 0.7 ± 0.6 per cent (range, 0.2 to 1.8 per cent) of the total area, and cartilage elsewhere along the base of the defect occupied 1.0 ± 1.6 per cent (range, 0 to 4.2 per cent). It also was found that 16 ± 26 per cent of the length of the base was covered by residual cartilage. The high coefficient of variation was due to an outlying value of 68 per cent (Fig. 1-A), one of 17 per cent, and four of less than 4 per cent (Figs. 1-B, 1-C, and 1-D).
    Histological analysis of serial sections of the fresh defects revealed three types of injury of the calcified cartilage: fracture at the edge of the defect, thinning, and microfracture. In four of the six defects, at least one large fracture (fifty to 100 micrometers wide) was noted at the extreme edge. This damage was consistent with overpenetration by the dermal punch when the defect was circumscribed. Two of these fractures extended through the calcified cartilage but only superficially into the subchondral bone (Fig. 1-C). The second type of damage, thinning of the zone of calcified cartilage, presumably was due to scraping of the base of the defect with the curet. Thinning of the calcified cartilage was inconsistent, varying from specimen to specimen (Figs. 1-A, 1-B, 1-C, and 1-D) and even within a given specimen. An average of 22 ± 14 per cent (range, 2 to 39 per cent) of the calcified cartilage was thinned or fractured. Finally, each of the five defects that contained little or no residual articular cartilage showed microfracturing of the surface of the calcified cartilage (Fig. 1-C), with a range of one or two microfractures per slide to ten or more per slide. None of the microfractures penetrated the underlying bone.
    In summary, one defect showed no thinning of the calcified cartilage but had much more residual cartilage than the other defects (Fig. 1-A). Two defects showed thinning of the calcified cartilage; a portion of the calcified layer (as much as 700 micrometers along the base) had been completely removed, with consequent damage to the underlying bone (Fig. 1-B). The depth of the remaining three defects generally extended to the tidemark, with little residual cartilage, and thinning (if any) was limited to the superficial portions of the calcified cartilage (Fig. 1-D). Some of these specimens had a corner fracture, and all had microfractures.

    Effects of Implantation of Cultured Autologous Chondrocytes

    All animals walked normally after removal of the external fixation. When the joints were opened, the synovial tissue appeared normal on gross examination, although there was evidence of slight hypertrophy or, less commonly, atrophy in certain joints. In one animal, the knee with two empty defects had substantial effusion with turbid synovial fluid and much more pronounced synovial hypertrophy at eighteen months. The patella appeared laterally displaced, and denuded cartilage on the trochlea and patella was consistent with patellar subluxation. These defects were excluded from subsequent analysis.
    No apparent differences were found among the three groups. All defects were distinguishable grossly from the surrounding cartilage, and there was variability in the filling and appearance. Repair tissue usually had a whiter, more opaque, and less glistening appearance than normal cartilage.

    Histological Findings

    No discernible differences were seen in the histological appearance of the repair tissue among the three treatment groups. Histological examination confirmed both the variable filling of the defects observed grossly and the over-all similarity of appearance of the lesions among the three groups (Figs. 2, 3, 4, 5, 6-A, 6-B and 6-C). Several defects were relatively unfilled, while others were filled with repair tissue to or above the level of the surrounding cartilage. In each treatment group, the repair tissue filling the eighteen-month-old defects displayed limited safranin-O staining of glycosaminoglycans as well as loss of staining in the adjacent cartilage (Figs. 2, 6-A, 6-B, and 6-C). The predominant types of tissue filling the eighteen-month-old defects in each group were transitional tissue and hyaline cartilage (Figs. 3, 4, 5, 6-A, 6-B and 6-C).
    Hyaline cartilage, especially that most similar to articular cartilage, formed preferentially at the base of the defect, most frequently in the corners, and was well bonded to the calcified layer. Much of the hyaline cartilage in the defect showed decreased staining with safranin O.
    Only five defects contained osseous repair tissue. These included one defect that had healed for eighteen months after implantation of cultured autologous chondrocytes (Fig. 2, A), two that had healed for twelve months after coverage with periosteum alone, as well as one that had healed for twelve months and one that had healed for eighteen months after no treatment. The tidemark partially reformed at an elevated level within one defect. In two others, it appeared that a new, elevated, calcified layer was forming, but the structure was abnormal.

    Histomorphometric Evaluation of the Tissue Filling the Defects

    The percentage of the total area of the defect filled by different types of tissue varied considerably from defect to defect, but the mean values were similar in all treatment groups (Fig. 7 and Table I). With use of two-way analysis of variance with respect to treatment and time, we could detect no significant differences among the three groups, with the numbers available. Analysis of variance, however, indicated several differences between the defects that had twelve months of healing and those that had eighteen months. The significant trends from twelve to eighteen months included increasing amounts of fibrous tissue (p = 0.029) and transitional tissue (p < 0.010). In addition, an increase in the total amount of repair tissue and a decrease in the amount of hyaline cartilage were found in all treatment groups at eighteen months compared with the amounts found at twelve months, but with the numbers available these trends did not meet our criteria for significance (p = 0.052 and p = 0.087, respectively).
    For completeness, the results at twelve and eighteen months were divided into critical healing categories (total filling and amount of hyaline cartilage) and examined with t tests for differences among the treatment groups. The t test was chosen over analysis of variance to take advantage of the paired comparison made possible by the presence of empty control defects and defects implanted with cultured autologous chondrocytes in the contralateral limbs of the same animal. The t tests for the group that had treatment of the defect with periosteum alone were unpaired. With the numbers available, we could detect no significant findings with the t test at either time-period.
    Bonding to the calcified cartilage was related to the amount of hyaline cartilage found at the base of the defect. The amount of bonding ranged from 41 to 60 per cent of the length of the base, excluding the empty defects evaluated after twelve months of healing, which had an outlying value of 89 per cent (Table II). With the numbers available, we could detect no significant difference among the groups (p = 0.44) with use of two-way analysis of variance. A prerequisite for bonding was an intact layer of calcified cartilage, which ranged from 65 to 98 per cent, and we could detect no difference among the treatment groups with two-way analysis of variance (p = 0.86). Integration with the adjacent cartilage was universally poorer than attachment to the base, ranging from 16 to 32 per cent (Table II). With two-way analysis of variance, we could detect no difference among the treatment groups (p = 0.90).

    Abnormal Changes in Bone and the Articular Cartilage Surrounding the Defect

    In all groups, reactions at the base of the defects sometimes resulted in disruption of the layer of calcified cartilage, penetration into the subchondral bone, and resorption of the subchondral bone, leading to decreased bone support under the defect (Table III, Fig. 6-C). Moderate or severe loss of bone was noted in five of the sixteen defects in which cultured autologous chondrocytes had been implanted, two of the twelve defects treated with periosteum alone, and three of the fourteen empty defects.
    Most samples of the articular cartilage adjacent to the defects showed cloning of chondrocytes and variable loss of safranin-O staining. Loss of safranin-O staining was greater in the defects that were sutured: moderate or severe loss occurred in eleven of the sixteen defects in which cultured autologous chondrocytes had been implanted and in seven of the twelve defects that had been treated with periosteum alone compared with only two of the fourteen empty defects (Table III, Figs. 6-A, 6-B, and 6-C). The area immediately adjacent to the defect was similar, with respect to cloning of chondrocytes and integrity of the tissue, among the treatment groups (Table III). About three-quarters of the defects in each group showed moderately or slightly increased cloning (Table III). The integrity of the surface layers was normal or only slightly changed in more than three-quarters of the defects in each group, while the deep tissue appeared normal in at least two-thirds of the defects in each group (Table III).
    Suturing often affected the adjacent articular cartilage more than 600 micrometers from the defect (Fig. 6-B). In certain cross sections, suturing of the periosteal flap was found to create clefts, completely separating the superficial layers from the deep layers of articular cartilage. Regions surrounding suture marks often displayed increased cloning and decreased safranin-O staining, and they occasionally showed complete disruption of normal architecture.
    Many specimens exhibited degenerative changes in the adjacent cartilage that may have been attributable to the operation or to the procedure to obtain chondrocytes for culture but not necessarily to the suturing. In the group that had implantation of cultured autologous chondrocytes and the group that had treatment with periosteum alone, these changes included cloning and loss of safranin-O staining beyond the suture marks (several millimeters from the edge of the defect). In addition, almost all of the empty defects, which had been subjected to the procedure to obtain chondrocytes but not to suturing, were associated with at least slight cloning in the cartilage far from the defect. Three of those eight knees, including the one excluded from grading, showed severe cloning, loss of safranin-O staining, and disruption of the normal collagen architecture across at least several millimeters of the articular surface. Furthermore, in two of those knees, pannus formed over the cartilage surface and in some locations invaded the superficial zone. In the knee that was excluded, the pannus completely covered the defects.
    In contrast to the findings in the rabbit model1,3, with the numbers available, we detected no significant effects of treatment with cultured autologous chondrocytes on the types and the amount of repair tissue. This may be explained by the differences in the species, the age of the animals, the lack of retention of the cells in the defect due to possible displacement of the periosteal flap, and the location of the defect (the patella compared with the trochlea).
    The finding of hyaline cartilage in the untreated control group in the canine model differed from the findings in the rabbit model1. In the rabbit model, in which a similar technique of areal analysis of sections made through the center of the defect was used, untreated defects were examined at twelve weeks only. At that time, these defects had significantly less reparative tissue and it was of significantly lower quality compared with the tissue in the defects treated with cultured autologous chondrocytes. At one year, sites that had been treated with cultured autologous chondrocytes were filled with significantly more reparative tissue than those that had been covered with the periosteal flap only (87 compared with 31 per cent). In the present canine model, treatment with cultured autologous chondrocytes was associated with the least filling after twelve months and after eighteen months, although with the numbers available we could detect no differences among the groups. In our study, a mean of 36 to 76 per cent of the area of the defect was filled with new repair tissue, a range that was similar to that seen in the study in the rabbit model1.
    Our finding that cultured autologous chondrocytes had no effect on the healing of defects in the distal part of the canine femur is not entirely inconsistent with the results reported in a clinical study by Brittberg et al.2. They found that treatment with cultured autologous chondrocytes was less successful in articular defects in the patellofemoral region than in those in the tibiofemoral articulation. Among the important differences between the canine and the human conditions is the thickness of the articular cartilage (approximately 0.7 millimeter for canine cartilage compared with three millimeters for human cartilage). The thickness of the cartilage affects the number of cells that can be injected and retained in a lesion. Although the findings of a short-term study of a canine model provided evidence that some injected chondrocytes had been retained in the defect six weeks after implantation4, the number of cells retained in the canine lesion relative to that retained in a defect in human cartilage has not been studied. Another important difference may be the weight-bearing patterns allowed postoperatively. Although weight-bearing by patients can be carefully controlled, it was necessary to rely on external fixation to limit motion and loading of the joint in the canine model.
    Because of the variability in the morphology of the fresh, untreated defects, the depth of the lesion may have been an important factor in determining which defects healed. We found that, although no bleeding was detected intraoperatively, variable damage occurred to the calcified cartilage. As several of the fresh defects showed evidence of slight penetrations through the calcified cartilage, some of the defects were technically full-thickness lesions, directly communicating with the underlying bone. The variability in depth also may have led to healing by different mechanisms—that is, the defects with penetration into the subchondral bone may have filled in partly with tissue from subchondral vasculature and marrow spaces, and these contributions would have been absent initially in the partial-thickness lesions.
    The variability in the extent of the lesion seemed to increase during the course of healing. In certain experimental defects, large portions of the calcified cartilage and subchondral bone were resorbed and eroded, forming deep osteochondral lesions. Furthermore, on the basis of the simultaneous observations of bone formation in the area of certain defects and of an intact but elevated tidemark, we suspected that damage to the calcified cartilage occurred early in the healing period and that the bone subsequently healed imperfectly—that is, with a change in the location of the tidemark—by the end point of the study. It was not possible to relate the pattern of healing in a specific defect with the pattern of injury to the zone of calcified cartilage and bone at the initial operation or to explain the reason for the changes in the underlying bone.
    Fibrous tissue, transitional tissue, and hyaline cartilage (including the more specialized articular cartilage) represented a full spectrum of reparative tissues. In many instances, one tissue was found blending into another, with a gradual change or mixture of cell and matrix characteristics. In other instances, the boundary between the types of tissue was found to be more abrupt. It is likely that there was some pattern of conversion of one type of tissue to another during the course of regeneration and possibly during degeneration as well. Additional observations are needed to characterize this pattern. A study to assess the mechanical and chemical regulators that may be important in this process also would be of interest.
    The amount of the subset of hyaline cartilage that met the histological criteria for articular cartilage was comparable with the amount of residual articular cartilage found in the fresh defects. Therefore, it was not possible to determine if any of the articular cartilage in the specimens examined at twelve and eighteen months had been newly synthesized. However, the amount of hyaline cartilage after one year was substantially higher than the residual amount in the fresh defects, thus indicating the formation of new tissue.
    Our observations indicate that suturing a periosteal flap to the defect was detrimental to the adjacent cartilage. Problems found in the adjacent cartilage included disruption of the tissue, loss of proteoglycans, and increased cloning of chondrocytes. Although the damage was pronounced in the dogs, the effects may be less pronounced in humans because of the increased thickness of the cartilage.
    Although some regeneration of hyaline cartilage was found at eighteen months, there was substantially less than that found at twelve months. Thus, the situation was not considered likely to improve. In addition, the presence of degenerative changes at both times suggested that all treatments had undesirable effects on the joint. Due to the similar profiles of reparative tissue types after the longest time-interval in this model, changes after an even longer time are expected to be similar in all treatment groups.
    NOTE: The authors appreciate the consultation on tissue-typing criteria with Dr. Andrew E. Rosenberg.
    Brittberg, M.; Nilsson, A.; Lindahl, A.; Ohlsson, C.; and Peterson, L.: Rabbit articular cartilage defects treated with autologous cultured chondrocytes. Clin. Orthop.,326: 270-283, 1996.326270  1996  [PubMed]
     
    Brittberg, M.; Lindahl, A.; Nilsson, A.; Ohlsson, C.; Isaksson, O.; and Peterson, L.: Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. New England J. Med.,331: 889-895, 1994.331889  1994 
     
    Grande, D. A.; Pitman, M. I.; Peterson, L.; Menche, D.; and Klein, M.: The repair of experimentally produced defects in rabbit articular cartilage by autologous chondrocyte transplantation. J. Orthop. Res.,7: 208-218, 1989.7208  1989  [PubMed]
     
    Shortkroff, S.; Barone, L.; Hsu, H. P.; Wrenn, C.; Gagne, T.; Chi, T.; Breinan, H.; Minas, T.; Sledge, C. B.; Tubo, R.; and Spector, M.: Healing of chondral and osteochondral defects in a canine model: the role of cultured chondrocytes in regeneration of articular cartilage. Biomaterials,17: 147-154, 1996.17147  1996  [PubMed]
     

    Submit a comment

    Topics

    Anchor for JumpAnchor for Jump
    +Figs. 1-A through 1-D: Light micrographs of specimens from the fresh, untreated defects. The adjacent cartilage, stained red with safranin O, is visible to one side of each defect (solid arrow). The subchondral bone (SCB) is stained blue with fast green. Fig. 1-A: Specimen from the outlier defect, which had the most residual cartilage (RC) at the base.
    Anchor for JumpAnchor for Jump
    +Fig 1-B Specimen from one of two defects that had injury through the calcified cartilage caused by the curet. The marrow space was violated near the edge of the defect (open arrow).
    Anchor for JumpAnchor for Jump
    +Fig. 1-C Specimen from a defect in which the most residual cartilage is in a corner and there is a corner fracture (open arrow) through the calcified cartilage. The calcified layer to the right of the residual cartilage is thinned and has several microfractures (small arrows).
    Anchor for JumpAnchor for Jump
    +Fig. 1-D Specimen from a defect from which virtually all articular cartilage had been removed to the level of the tidemark.
    Anchor for JumpAnchor for Jump
    +Fig. 2 Light micrograph of reparative tissue from three specimens that had safranin-O and fast-green staining after eighteen months of healing. Each defect has a fully intact plate of subchondral bone and more-than-average filling. The arrowheads indicate the approximate borders of the defects at the surface. Variable loss of safranin-O staining in adjacent cartilage is visible in all three specimens. A: Specimen from a defect in which cultured autologous chondrocytes were implanted. There is bone formation in the deep layers of the center of the defect with good integration with adjacent cartilage. B: Specimen from a defect that was covered with periosteum alone. C: Specimen from an empty defect.
    Anchor for JumpAnchor for Jump
    +Fig. 3 Light micrograph showing reparative tissue in the center eighteen months after implantation of cultured autologous chondrocytes (trichrome). Hyaline cartilage (HC) formed at the base of the defect. Transitional tissue (TT) overlays the hyaline cartilage and is smoothly integrated in places. Hyaline cartilage bonded to calcified cartilage (CC). SCB = subchondral bone.
    Anchor for JumpAnchor for Jump
    +Fig. 4 Light micrograph (the same specimen as in Fig. 2, B) showing reparative tissue at the edge of a defect eighteen months after coverage with periosteum alone (trichrome). Newly formed tissue consists of transitional tissue (TT) and hyaline cartilage (HC), including a portion similar to articular cartilage (AC). The hyaline cartilage bonded to the calcified cartilage (CC). Evidence of poor bonding of reparative tissue to the adjacent cartilage is visible at the edge of the defect (arrowhead).
    Anchor for JumpAnchor for Jump
    +Fig. 5 Light micrograph showing reparative tissue at the edge of the specimen eighteen months after creation of a defect that was left untreated. Hyaline cartilage (HC) formed only in the corner of the defect while most of the defect was filled with transitional tissue (TT). Substantial cloning of chondrocytes is seen in the hyaline cartilage. The collagen fibers of the transitional tissue are not continuous with the calcified cartilage (CC), indicating apposition instead of bonding as seen with hyaline cartilage. Poor bonding of reparative tissue to the adjacent cartilage is seen at the edge of the defect (arrowhead). SCB = subchondral bone.
    Anchor for JumpAnchor for Jump
    +Figs. 6-A, 6-B, and 6-C: Light micrographs showing relatively poor repair (safranin O-fast green) after eighteen months of healing. The arrowheads indicate the approximate borders of the defects at the surface. Fig. 6-A: Specimen from a defect in which cultured autologous chondrocytes had been implanted. The defect is predominantly empty, and there is evidence of remodeling in the subchondral bone (open arrow).
    Anchor for JumpAnchor for Jump
    +Fig. 6-B Specimen from a defect that was covered with periosteum alone. The defect is empty except in the corner, where there is a small amount of hyaline cartilage (open arrow). The adjacent cartilage still shows the path of a suture (solid arrow), with obvious mechanical disruption and loss of some safranin-O staining. The damage of subchondral bone is an artefact of processing.
    Anchor for JumpAnchor for Jump
    +Fig. 6-C Specimen from an empty defect. There is substantial erosion of the calcified cartilage to the left of the open arrow, with accompanying resorption of the underlying bone. Fibrocartilaginous transitional tissue (TT) fills portions of the defect and the bone.
    Anchor for JumpAnchor for Jump
    +Fig. 7 Bar graph showing the composition of the tissue found in the full-thickness defects as a function of time and treatment. The percentages are mean values. The group of fresh, untreated defects also is shown in order to depict the level of residual cartilage left in the lesions. The total height of the column represents the total filling of the defect. With analysis of variance, we could detect no differences among the treatment groups with regard to any type of tissue (p > 0.05). CAC = implantation of cultured autologous chondrocytes, P = coverage with a periosteal flap only, and EC = no treatment.
    Anchor for JumpAnchor for Jump  TABLE I FILLING OF DEFECTS BY DIFFERENT TYPES OF TISSUE*
    *The values are given as the mean and the standard error of the mean for the percentage of the total area of the defect filled with a particular type of tissue. N = number of defects.†Subset of hyaline cartilage that has characteristics of articular cartilage, including columnar arrangement of cells and strong safranin-O staining of matrix for proteoglyans.‡The total value does not include the values for matrix flow or the subset of hyaline cartilage.§Given for the individual defects.
    At Twelve MonthsAt Eighteen Months
    Type of tissueDefects Treated with Cult. Autol. Chondrocytes (N = 8)Defects Treated with Periosteum Only (N = 6)Empty Defects (N = 8)Defects Treated with Cult. Autol. Chondrocytes (N = 8)Defects Treated with Periosteum Only (N = 6)Empty Defects (N = 6)
    Matrix flow3 ± 13 ± 22 ± 12 ± 12 ± 12 ± 1
    Fibrous tissue2 ± 12 ± 11 ± 12 ± 12 ± 18 ± 3
    Transition tissue19 ± 828 ± 1417 ± 828 ± 841 ± 852 ± 8
    Hyaline cartilage15 ± 316 ± 1323 ± 513 ± 410 ± 310 ± 2
    Articular cartilage†0.5 ± 0.32 ± 24 ± 20.3 ± 0.30.4 ± 0.40 ± 0
    Bone0 ± 02 ± 10.2 ± 0.23 ± 30 ± 06 ± 6
    Total36 ± 1048 ± 1041 ± 446 ± 853 ± 676 ± 18
    Range§13—7117—7328—7216—7614—7942—36
    Anchor for JumpAnchor for Jump  TABLE II BONDING OF REPARATIVE TISSUE TO CALCIFIED CARTILAGE AND TO ADJACENT CARTILAGE*
    *The values are given as the mean and the standard error of the mean for the percentage of the total length of the calcified cartilage or the articular cartilage that was bonded to the reparative tissue.
    At Twelve MonthsAt Eighteen Months
    Defects Treated with Cult. Autol. Chrondrocytes (N = 8)Defects Treated with Peristeum Only (N = 6)Empty Defects (N = 8)Defects Treated with Cult. Autol. Chrondrocytes (N = 8)Defects Treated with Periosteum Only (N = 6)Empty Defects (N = 6)
    Calcified cartilage60 ± 1244 ± 2989 ± 1059 ± 2047 ± 1441 ± 16
    Adjacent cartilage21 ± 432 ± 416 ± 822 ± 516 ± 725 ± 9
    Anchor for JumpAnchor for Jump  TABLE III GRADING OF ABNORMAL CHANGES IN ARTICULAR CARTILAGE AND BONE IN THE DEFECTS*
    *The data combines the results at the twelve and eighteen-month examinations, and the values are given as the number of defects. N = number of defects.†0 points = severe change, 1 point = moderate change, 2 points = slight change, and 3 points = normal findings or no change.
    Changes in Adjacent Articular Cartilage†
    Changes in Bone†Loss of Safranin-O StainingCloningSurface IntegrityDeep-Tissue Integrity
    0 Points1 Point2 Points3 Points0 Points1 Point2 Points3 Points0 Points1 Point2 Points3 Points0 Points1 Point2 Points3 Points0 Points1 Point2 Points3 Points
    Defects treated with cultured autologous chondrocytes (n=16)4174922326620210402311
    Defects treated with periosteum only (n=12)11466132245101650138
    Empty defects (n=14)1211002931571128310112
    Brittberg, M.; Nilsson, A.; Lindahl, A.; Ohlsson, C.; and Peterson, L.: Rabbit articular cartilage defects treated with autologous cultured chondrocytes. Clin. Orthop.,326: 270-283, 1996.326270  1996  [PubMed]
     
    Brittberg, M.; Lindahl, A.; Nilsson, A.; Ohlsson, C.; Isaksson, O.; and Peterson, L.: Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. New England J. Med.,331: 889-895, 1994.331889  1994 
     
    Grande, D. A.; Pitman, M. I.; Peterson, L.; Menche, D.; and Klein, M.: The repair of experimentally produced defects in rabbit articular cartilage by autologous chondrocyte transplantation. J. Orthop. Res.,7: 208-218, 1989.7208  1989  [PubMed]
     
    Shortkroff, S.; Barone, L.; Hsu, H. P.; Wrenn, C.; Gagne, T.; Chi, T.; Breinan, H.; Minas, T.; Sledge, C. B.; Tubo, R.; and Spector, M.: Healing of chondral and osteochondral defects in a canine model: the role of cultured chondrocytes in regeneration of articular cartilage. Biomaterials,17: 147-154, 1996.17147  1996  [PubMed]
     
    Accreditation Statement
    These activities have been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Academy of Orthopaedic Surgeons and The Journal of Bone and Joint Surgery, Inc. The American Academy of Orthopaedic Surgeons is accredited by the ACCME to provide continuing medical education for physicians.
    CME Activities Associated with This Article
    Submit a Comment
    Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
    Comments are moderated and will appear on the site at the discretion of JBJS editorial staff.

    * = Required Field
    (if multiple authors, separate names by comma)
    Example: John Doe




    Related Articles
    Related Cases
    Related Content
    Topic Collections
    Related Audio and Videos
    PubMed Articles
    Clinical Trials
    Readers of This Also Read...
    jbjs jobs
    12/22/2011
    VA - Charleston Area Medical Center
    12/22/2011
    ME - Central Maine Medical Center
    12/22/2011
    Maine - Central Maine Medical Center